Replies to post #78373 on Cytodyn Inc (CYDY)

[Venture_Cap]

If they truly have supply chain agreements for $1.362billion pending FDA approval I’m sure that would play into it.

Also, I’m sure NP knows much more about FDA status and funding than we do. All seem very confident right now.

The future exchange would love to have them before FDA approval hits.

[Saltz]

Mulholland has been around from the genesis of Cytodyn. This guy understands the intricacies of what it will takes to uplist better than anyone. He will slow play whatever CYDY’s strategy is — unlike Naders over promise under deliver track record. The uplist will be timed perfectly to maximize valuation and minimize potential failure. Mulholland knows he is sitting on a keg of dynamite and will not screw up lighting the fuse prematurely.